GlaxoSmithKline CEO Emma Walmsley has appointed Iain Mackay from HSBC as its new chief financial officer. GSK had previously announced that current CFO Simon Dingemans would retire in May 2019.
Mackay has also been appointed as an executive director to the GSK Board and will join the drugmaker on January 14, 2019.
Mackay was been the group finance director at HSBC for the last 8 years. Mackay has worked in Asia, the U.S. and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse. He is a trustee of the British Heart Foundation and a member of the Court of the University of Aberdeen.
"I’m delighted to welcome Iain to GSK. As a proven CFO of a complex, regulated global organisation, he brings tremendous finance experience and will be a great addition to the team," said Walmsley. "He is a strong leader with a track record of driving cost, cash and capital allocation discipline to deliver strategy. These capabilities will be vital as we continue to implement our Innovation, Performance and Trust priorities for the benefit of patients and shareholders."
Dingemans will continue to be accountable as CFO for GSK’s financial governance through March 2019.
Read the full release